The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...

Please provide your email address to receive an email when new articles are posted on . A 55-year-old man at Tufts Medical Center for hypovolemic shock due to a gastrointestinal hemorrhage was ...

Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...

The correct diagnosis of anterior optic neuritis was made based on the correlation of onset of decreased vision, pain on EOM testing, presence of an APD, decreased color vision and red desaturation, ...

"Patients with anti-AQP4-Ab may basically need long-term relapse prevention, because they surely experience much higher relapse activity, with much worse neurological disturbance…In MOGAD patients, ...